Doximity, Inc. SEC Filings

Doximity, Inc. director Kira Scherer Wampler reported several related equity transactions. On March 3, 2026, she exercised a stock option for 2,000 shares at a price of $0.0000 per share, increasing her direct option-related holdings to 456,700 shares as of that date.

On the same date, 2,000 shares of Class B Common Stock converted into 2,000 shares of Class A Common Stock at a conversion price of $0.0000 per share, and the Class B position from this lot went to 0 shares. After this conversion, her direct Class A holdings were 21,839 shares.

Also on March 3, 2026, Wampler completed an open-market sale of 2,000 shares of Class A Common Stock at a price of $26.0000 per share, leaving her with 19,839 shares of Class A Common Stock held directly. According to a footnote, these sales occurred automatically under a Rule 10b5-1 trading plan adopted on November 12, 2024, indicating they were pre-scheduled rather than discretionary trades.

DOCS reported a proposed sale of 2,000 common shares via a stock option exercise on 03/03/2026. The filing lists the sale as through the issuer for cash.

It also discloses prior sales by KIRA WAMPLER, including 2,000 shares on 02/02/2026 for $74,660.00 and 2,000 shares on 01/02/2026 for $89,300.00.

Doximity, Inc. reported that interim PFO and PAO Sitaram Siddharth had several equity transactions in Class A common stock. He received a grant of 9,992 restricted stock units on February 15, 2026, which vest in equal quarterly installments over 33 months beginning on May 15, 2026, contingent on continued service. Each unit represents one share of Class A stock. On the same date, 946 shares were withheld by Doximity to cover tax obligations related to previously granted RSUs, a mandatory withholding rather than a discretionary sale. Siddharth also acquired 384 shares through the 2021 Employee Stock Purchase Plan at a price equal to 85% of the February 15, 2026 closing price, bringing his directly held stake to 78,733 shares of Class A common stock.

Doximity, Inc. Chief Financial Officer Anna Bryson reported two equity-related transactions in Class A Common Stock. She received a grant of 152,258 restricted stock units on February 15, 2026, with each RSU representing one share and vesting in equal quarterly installments over 12 months, subject to continued service.

On the same date, 11,381 shares of Class A Common Stock were withheld at $25.02 per share to satisfy tax-withholding obligations tied to previously granted RSUs. According to the disclosure, this withholding followed a pre-established issuer election and is described as a non-discretionary, tax-related disposition rather than an open-market trade.

Doximity, Inc. Chief Executive Officer Jeffrey Tangney reported a tax-related share disposition involving the company’s Class A Common Stock. On February 15, 2026, 8,243 shares were withheld by Doximity to cover tax obligations tied to vesting restricted stock units previously granted to him.

The filing specifies this was a mandated tax-withholding disposition, not a discretionary trade in the open market. After this withholding, Tangney’s directly held Class A Common Stock position reported in the filing stands at 2,232,810 shares.

Doximity, Inc. officer Sitaram Siddharth filed an initial Form 3 reporting his equity holdings. He directly holds 69,303 shares of Class A Common Stock, including several restricted stock unit (RSU) awards that vest quarterly over 36–48 months starting on May 15, 2023, May 15, 2024, and May 15, 2025, subject to continued service.

He also holds stock options to acquire 93,800 shares of Class B Common Stock at an exercise price of $4.12 per share expiring on December 21, 2030, and 70,000 shares at $8.26 per share expiring on February 15, 2031. Each share of Class B Common Stock is convertible into one share of Class A Common Stock under specified conditions.

Doximity, Inc. reported solid growth for the quarter ended December 31, 2025. Revenue rose to $185.1 million from $168.6 million, while net income declined to $61.6 million from $75.2 million as operating expenses, including stock-based compensation, increased.

For the first nine months, revenue reached $499.5 million and net income was $176.9 million, both higher than a year earlier. The company generated $216.9 million in operating cash flow, held $64.8 million in cash plus $670.3 million in marketable securities, and spent $342.9 million on share repurchases.

Doximity closed the $36.3 million Pathway Medical acquisition, adding AI-based medical technology and goodwill, and ended with 126 customers generating at least $500,000 of trailing 12‑month subscription revenue, accounting for about 84% of revenue. Net revenue retention was 112%, indicating continued expansion within existing customers.

Doximity, Inc. reported that it issued a press release with financial results for its fiscal quarter ended December 31, 2025, and furnished that release as an exhibit. The company also announced that Chief Financial Officer and principal accounting officer Anna Bryson is taking a temporary medical leave. Effective February 3, 2026, Chief Accounting Officer Siddharth Sitaram was appointed interim principal financial officer and interim principal accounting officer, continuing a leadership team with deep internal experience at the company.

FMR LLC and Abigail P. Johnson filed Amendment No. 5 to a Schedule 13G reporting their beneficial ownership of Doximity Inc. Class A common stock as of 12/31/2025. They report beneficial ownership of 2,164,071.69 Class A shares, representing 1.6% of the outstanding class.

FMR LLC reports sole voting power over 2,155,851.97 shares and sole dispositive power over 2,164,071.69 shares, with no shared voting or dispositive power. The securities are certified as acquired and held in the ordinary course of business, without the purpose or effect of changing or influencing control of Doximity.